Recombinant Her2 (ERBB2) Protein

Sign InRegister

English

Her2 Overview

Molecule Name

Receptor protein-tyrosine kinase erbB-2

Synonyms

ERBB2,CD340,HER-2,neu,HER2,MLN19,NEU,NGL,TKR1

Drug Development Progress

Drugs in Clinical Trials229

Approved Drugs48

Highest Development StageApproved

Target Synonym

EC 2.7.10.1，HER-2/Neu，Herstatin，HER-2，TKR1，Receptor， ErbB-2，V-Erb-B2 Erythroblastic Leukemia Viral Oncogene Homolog 2， Neuro/Glioblastoma Derived Oncogene Homolog，V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncoprotein 2，Neuroblastoma/Glioblastoma Derived Oncogene Homolog，C-Erb B2/Neu Protein，CD340 Antigen，EC:2.7.10.1，EC 2.7.10，MLN 19，CD340，Tyrosine kinase-type cell surface receptor HER2，Receptor tyrosine-protein kinase erbB-2，ERBB2，MLN19，Proto-oncogene Neu，Erb-B2 Receptor Tyrosine Kinase 2，V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2，Neuro/Glioblastoma Derived Oncogene Homolog，Human Epidermal Growth Factor Receptor 2，Metastatic Lymph Node Gene 19 Protein，Proto-Oncogene C-ErbB-2，P185erbB2，HER2，NGL，NEU，V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (Neuro/Glioblastoma Derived Oncogene Homolog)

Background

Human Epidermal growth factor Receptor 2 (HER2) is also called ERBB2, HER-2,HER-2 /neu, NEU, NGL,TKR1 and c-erb B2,and is a protein giving higher aggressiveness in breast cancers. It is a member of the ErbB protein family, more commonly known as the epidermal growth factor receptor family. HER2 is a cell membrane surface-bound receptor tyrosine kinase and is normally involved in the signal transduction pathways leading to cell growth and differentiation. HER2 is thought to be an orphan receptor, with none of the EGF family of ligands able to activate it. Approximately 30% of breast cancers have an amplification of the HER2 gene or overexpression of its protein product. Overexpression of this receptor in breast cancer is associated with increased disease recurrence and worse prognosis. HER2 appears to play roles in development, cancer, communication at the neuromuscular junction and regulation of cell growth and differentiation .

Her2 Product List

Molecule	Cat. No.	Product Name	Species	Host	Purity	Activity	Size&Price
Her2	HOTAIDD‑Ready HE2-H5212	Human Her2 / ErbB2 Protein, Tag Free (MALS verified)	Human	HEK293	MALSSDS-PAGE	ELISABLI	$345.00 50ug
Her2	HOTAvitagAIDD‑Ready HE2-H82E2	Biotinylated Human Her2 / ErbB2 Protein, His,Avitag™, premium grade	Human	HEK293	MALSSDS-PAGE	ELISASPRFlowTR-FRET	$415.00 25ug
Her2	HOTAIDD‑Ready HE2-H5225	Human Her2 / ErbB2 Protein, His Tag (Mass Spec & MALS verified)	Human	HEK293	MALSSDS-PAGE	ELISASPRBLITR-FRET	$435.00 100ug
Her2	HOTAIDD‑Ready HE2-H822R	Biotinylated Human Her2 / ErbB2 Protein, His Tag, ultra sensitivity (primary amine labeling, long spacer) (MALS verified)	Human	HEK293	MALSSDS-PAGE	ELISABLIFlow	$345.00 25ug
Her2	ER2-M5220	Mouse Her2 / ErbB2 Protein, His Tag (MALS verified)	Mouse	HEK293	MALSSDS-PAGE		$360.00 100ug
Her2	HE2-C5253	Cynomolgus Her2 / ErbB2 Protein, Fc Tag	Cynomolgus	HEK293	SDS-PAGE	ELISA	$370.00 100ug
Her2	AIDD‑Ready HE2-C52Hb	Cynomolgus Her2 / ErbB2 Protein, His Tag (MALS verified)	Cynomolgus	HEK293	MALSSDS-PAGE	ELISABLI	$310.00 100ug
Her2	Avitag HE2-C82E3	Biotinylated Cynomolgus Her2 / ErbB2 Protein, His,Avitag™ (MALS verified)	Cynomolgus	HEK293	MALSSDS-PAGE	ELISA	$360.00 25ug
Her2	Avitag HE2-C82F3	Biotinylated Cynomolgus Her2 / ErbB2 Protein, Fc,Avitag™	Cynomolgus	HEK293	SDS-PAGE	ELISA	$370.00 25ug
Her2	HE2-H5253	Human Her2 / ErbB2 Protein, Fc Tag, premium grade	Human	HEK293	MALSSDS-PAGE	ELISA	$315.00 100ug

Her2 >

HotAIDD‑Ready

Human Her2 / ErbB2 Protein, Tag Free (MALS verified)

Cat. No. HE2-H5212

Species

Human

Host

HEK293

Purity

MALSSDS-PAGE

Activity

ELISABLI

$345.00

Her2 >

HotAvitagAIDD‑Ready

Biotinylated Human Her2 / ErbB2 Protein, His,Avitag™, premium grade

Cat. No. HE2-H82E2

Species

Human

Host

HEK293

Purity

MALSSDS-PAGE

Activity

ELISASPRFlowTR-FRET

$415.00

Her2 >

HotAIDD‑Ready

Human Her2 / ErbB2 Protein, His Tag (Mass Spec & MALS verified)

Cat. No. HE2-H5225

Species

Human

Host

HEK293

Purity

MALSSDS-PAGE

Activity

ELISASPRBLITR-FRET

$435.00

Her2 >

HotAIDD‑Ready

Biotinylated Human Her2 / ErbB2 Protein, His Tag, ultra sensitivity (primary amine labeling, long spacer) (MALS verified)

Cat. No. HE2-H822R

Species

Human

Host

HEK293

Purity

MALSSDS-PAGE

Activity

ELISABLIFlow

$345.00

Her2 >

Mouse Her2 / ErbB2 Protein, His Tag (MALS verified)

Cat. No. ER2-M5220

Species

Mouse

Host

HEK293

Purity

MALSSDS-PAGE

$360.00

Her2 >

Cynomolgus Her2 / ErbB2 Protein, Fc Tag

Cat. No. HE2-C5253

Species

Cynomolgus

Host

HEK293

Purity

SDS-PAGE

Activity

ELISA

$370.00

Her2 >

AIDD‑Ready

Cynomolgus Her2 / ErbB2 Protein, His Tag (MALS verified)

Cat. No. HE2-C52Hb

Species

Cynomolgus

Host

HEK293

Purity

MALSSDS-PAGE

Activity

ELISABLI

$310.00

Her2 >

Avitag

Biotinylated Cynomolgus Her2 / ErbB2 Protein, His,Avitag™ (MALS verified)

Cat. No. HE2-C82E3

Species

Cynomolgus

Host

HEK293

Purity

MALSSDS-PAGE

Activity

ELISA

$360.00

Her2 >

Avitag

Biotinylated Cynomolgus Her2 / ErbB2 Protein, Fc,Avitag™

Cat. No. HE2-C82F3

Species

Cynomolgus

Host

HEK293

Purity

SDS-PAGE

Activity

ELISA

$370.00

Her2 >

Human Her2 / ErbB2 Protein, Fc Tag, premium grade

Cat. No. HE2-H5253

Species

Human

Host

HEK293

Purity

MALSSDS-PAGE

Activity

ELISA

$315.00

You Have Viewed 1-10 Of 35 Results

Anti-Her2 II / Anti-Her2 IV Bi-specific antibody ADC

Drug Type

Bioconjugates

Therapeutic Area

Oncology/Cancer

Indications

Solid tumor

Stage

Preclinical

Rights Region

Global

Her2xCD3 BsAb

Drug Type

Bispecific antibody

Therapeutic Area

Oncology/Cancer

Indications

HER2-positive Cancer

Stage

Phase I

Rights Region

Global

No Data

Asset Licensing Opportunity

Project Cooperation

Project Name	Drug Type	Therapeutic Area	Indication	Stage	Rights Area
Her2xCD3 BsAb	Bispecific antibody	Oncology/Cancer	HER2-positive Cancer	Phase I	Global
Anti-Her2 II / Anti-Her2 IV Bi-specific antibody ADC	Bioconjugates	Oncology/Cancer	Solid tumor	Preclinical	Global

Project Name: Her2xCD3 BsAb
Drug Type: Bispecific antibody
Therapeutic Area: Oncology/Cancer
Indication: HER2-positive Cancer
Stage: Phase I
Rights Area: Global

Project Name: Anti-Her2 II / Anti-Her2 IV Bi-specific antibody ADC
Drug Type: Bioconjugates
Therapeutic Area: Oncology/Cancer
Indication: Solid tumor
Stage: Preclinical
Rights Area: Global

Resources

Clinical Drug Information

English Name	Research Code	Highest Development Stage	Company	Indication	Clinical Trial
Recombinant anti-HER2 humanized monoclonal antibody (Shanghai Institute of Biological Products)	SIBP-01	Phase 3 Clinical	Shanghai Institute of Biological Products Co Ltd	Breast Neoplasms; Stomach Neoplasms	Details
Anvatabart opadotin	NCB-001; JNJ-0683; ARX-788	Phase 3 Clinical	Ambrx Inc	Bile Duct Neoplasms; Breast Neoplasms; Gastroesophageal Junction Neoplasms; Metastatic breast cancer; Neoplasms; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms	Details
Sacibertinib	Hemay-022	Phase 3 Clinical	Tianjin Hemay Pharmaceutical Co Ltd, Xiajiang Hemei Pharmaceutical Co Ltd	Breast Neoplasms; Foodborne Diseases	Details
Pertuzumab biosimilar（Hisun Pharm）	HS-627; HS627	Phase 3 Clinical	Beijing Mabworks Biotech Co Ltd, Zhejiang Hisun Pharmaceutical Co Ltd	Breast Neoplasms	Details
Recombinant human neuregulin-1	rhNRG-1	Phase 3 Clinical	Zensun (Shanghai) Sci&Tech Co Ltd	Heart Failure; Heart Failure, Diastolic; Heart Failure, Systolic; Myocardial Infarction	Details
Caxmotabart Entudotin	FS-1502; LCB14-0110; LCB-14-0110; IKS014; IKS-014; LCB-14	Phase 3 Clinical	Legochembio	Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Gastroesophageal Junction Neoplasms; Metastatic breast cancer; Solid tumours; Stomach Neoplasms	Details
HLX-22	AC-101; HLX-22; HLX22	Phase 3 Clinical	Atlas Therapeutics AB	Breast Neoplasms; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Solid tumours; Stomach Neoplasms	Details
Coprelotamab	GB-221	Phase 3 Clinical	Genor Biopharma Co Ltd	Breast Neoplasms; Metastatic breast cancer	Details
Trastuzumab vedotin	MRG-002	Phase 3 Clinical	Shanghai Miracogen Inc	Adenocarcinoma; Bile Duct Neoplasms; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Metastatic breast cancer; Solid tumours; Stomach Neoplasms	Details
trastuzumab biosimilar (Hetero)	Ado-Trastuzumab biosimilar (Hetero)	Phase 3 Clinical	Hetero Drugs Ltd	Neoplasms	Details
T‑Bren	BLM07D1; BL-M07D1	Phase 3 Clinical	Sichuan Baili Pharmaceutical Co Ltd, SystImmune	Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Endometrial Neoplasms; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Gastrointestinal Neoplasms; Genital Neoplasms, Female; Lung Neoplasms; Ovarian Neoplasms; Solid tumours; Stomach Neoplasms; Urogenital Neoplasms; Uterine Cervical Neoplasms	Details
Pertuzumab biosimilar(Zydus Cadila)	ZRC-3277	Phase 3 Clinical	Zydus Cadila	Metastatic breast cancer	Details
HL-02	HL-02	Phase 3 Clinical	Hualan Ankang Biotechnology Co Ltd	Breast Neoplasms	Details
JSKN-003	JSKN-003	Phase 3 Clinical	Alphamab Oncology	Breast Neoplasms; Carcinoma, Ovarian Epithelial; Colorectal Neoplasms; Esophageal Neoplasms; Fallopian Tube Diseases; Fallopian Tube Neoplasms; Neoplasms; Ovarian Neoplasms; Peritoneal Diseases; Peritoneal Neoplasms; Solid tumours; Stomach Neoplasms	Details
Trastuzumab biosimilar (Hetero Biopharma)		Phase 3 Clinical	Hetero Biopharma Ltd	Breast Neoplasms	Details
Ado Trastuzumab Emtansine biosimilar (Hetero Biopharma)	HBP 6	Phase 3 Clinical	Hetero Biopharma Ltd	Breast Neoplasms	Details
IBI-354	IBI-354	Phase 3 Clinical		Breast Neoplasms; Fallopian Tube Neoplasms; Metastatic breast cancer; Ovarian Diseases; Ovarian Neoplasms; Peritoneal Diseases; Peritoneal Neoplasms; Solid tumours	Details
TQB-2102	TQB2102; TQB-2102	Phase 3 Clinical	Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group	Bile Duct Neoplasms; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Genital Neoplasms, Female; Metastatic breast cancer; Neoplasms; Solid tumours; Stomach Neoplasms	Details
TQB-2930	TQB-2930	Phase 3 Clinical	Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group	Breast Neoplasms; Metastatic breast cancer; Neoplasms; Solid tumours	Details
HER2/Neu GP2 vaccine(Greenwich LifeSciences Inc/NuGenerex Immuno Oncology)	GLSI-100	Phase 3 Clinical	Antigen Express Inc, Norwell Inc	Breast Neoplasms	Details
Trastuzumab pamirtecan	DB-1303; BNT323	Phase 3 Clinical	Duality Biologics (Suzhou) Co Ltd	Breast Neoplasms; Endometrial Neoplasms; Metastatic breast cancer; Neoplasm Metastasis; Solid tumours	Details
GQ-1005	GQ-1005; GQ1005	Phase 3 Clinical	GeneQuantum Healthcare (Suzhou) Co Ltd	Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasms; Solid tumours	Details
Trastuzumab biosimilar(Aprogen/Nichi-Iko)	AP-06	Phase 3 Clinical	Aprogen, Nichi-Iko Pharmaceutical Co Ltd	Breast Neoplasms	Details
Pertuzumab biosimilar (Xuanzhu/SL)	KM-118; KM118; XZP-KM118	Phase 3 Clinical	Beijing Sl Pharmaceutical Co Ltd, Xuanzhu (Shijiazhuang) Biotechnology Co Ltd	Breast Neoplasms	Details
Pertuzumab biosimilar (CinnaGen)		Phase 3 Clinical	Cinnagen	Breast Neoplasms	Details
IAH-0968	IAH0968; IAH-0968	Phase 3 Clinical	SunHo (China) BioPharmaceutical Co Ltd	Biliary Tract Neoplasms; Colorectal Neoplasms; Solid tumours; Stomach Neoplasms	Details
BAT-1006	BAT-1006	Phase 3 Clinical	Bio-Thera Solutions Ltd	Breast Neoplasms; Solid tumours	Details
Trastuzumab envedotin	DP-303c; DP303c; SYSA1501; SYSA-1501	Phase 3 Clinical	CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd	Breast Neoplasms; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Metastatic breast cancer; Neoplasms; Ovarian Neoplasms; Salivary Gland Neoplasms; Solid tumours; Stomach Neoplasms	Details
Larotinib Mesylate	Z-650	Phase 3 Clinical	Guangdong Dongyangguang Pharmaceutical Co Ltd	Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Pancreatic Neoplasms; Solid tumours	Details
DF-1001	DF-1001	Phase 2 Clinical	Dragonfly Therapeutics Llc	Solid tumours	Details
TPIV-100 (TapImmune)	TPIV-100	Phase 2 Clinical	Mayo Clinic	Breast Neoplasms; Breast Neoplasms, Male; Carcinoma, Intraductal, Noninfiltrating	Details
BB-1701	BB-1701	Phase 2 Clinical	Bliss Biopharmaceutical (Hangzhou) Co Ltd	Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Metastatic breast cancer; Solid tumours; Stomach Neoplasms	Details
Sapitinib	AZD-8931	Phase 2 Clinical	Astrazeneca Plc	Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Esophageal Neoplasms; Metastatic breast cancer; Neoplasm Metastasis; Neoplasms; Solid tumours; Stomach Neoplasms	Details
Anti-CD3 and anti-HER2 BiTE-expressing T cell (MedImmune)		Phase 2 Clinical	Huazhong University Of Science And Technology, Medimmune, University Of Michigan, University Of Virginia Cancer Center	Breast Neoplasms	Details
RG-6596	ZN-1041; RG-6596; ZN-A-1041	Phase 2 Clinical	Suzhou Zanrong Pharmaceutical Technology Co Ltd	Breast Neoplasms; Solid tumours	Details
AU-101	AU-101	Phase 2 Clinical	Attralus Inc	Breast Neoplasms; Glioblastoma; Osteosarcoma	Details
Tesevatinib	XL-647; KD-020; KD-019; EXEL-7647	Phase 2 Clinical	Exelixis Inc	Brain metastases; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Glioblastoma; Neoplasm Metastasis; Neoplasms; Polycystic Kidney, Autosomal Dominant; Polycystic Kidney, Autosomal Recessive	Details
DX126-262	DAC-001; DX126-262	Phase 2 Clinical	Hangzhou Dac Biotech Company Ltd	Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Metastatic breast cancer; Stomach Neoplasms	Details
AMX-3009 Maleate	AMX-3009; AMX3009马来酸	Phase 2 Clinical	Anrun Medicine Technology (Suzhou) Co Ltd	Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Pancreatic Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms	Details
Allitinib Tosylate	AST-6; ALS-1306; AST-1306	Phase 2 Clinical	Shanghai Allist Pharmaceutical Technology Co Ltd	Breast Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
Cinrebafusp alfa	PRS-343	Phase 2 Clinical	Pieris Pharmaceuticals	Breast Neoplasms; Solid tumours; Stomach Neoplasms; Urinary Bladder Neoplasms	Details
AU-105	AU-105	Phase 2 Clinical	Attralus Inc	Glioblastoma	Details
Varlitinib Ditosylate	SPS-4370; ASLAN-001; ARRY-334543; ARRY-543; QBT-01	Phase 2 Clinical	Array Biopharma	Bile Duct Neoplasms; Biliary Tract Neoplasms; Breast Neoplasms; Cholangiocarcinoma; Metastatic breast cancer; Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms	Details
Selatinib Ditosilate	QLNC-120	Phase 2 Clinical	Qilu Antibiotics (Linyi) Pharmaceutical Co Ltd, Qilu Pharmaceutical Co Ltd	Breast Neoplasms	Details
HER2 cancer vaccine (BioLife Science)	PEV-6; PEV-6A; IMU-131	Phase 2 Clinical	Pevion Biotech Ltd	Adenocarcinoma; Gastroesophageal Junction Neoplasms; Gastrointestinal Neoplasms; Stomach Neoplasms	Details
AE-37/GP-2 vaccine	AE-37 (Generex Biotechnology Corporation)	Phase 2 Clinical	Generex Biotechnology Corp	Breast Neoplasms; Triple Negative Breast Neoplasms	Details
ADXS-31164	Lovaxin B; OST-HER2; OST31-164; ADXS31-164; ADXS-31164; ADXS-cHER2; ADXS-HER2	Phase 2 Clinical	University Of Pennsylvania	Bone Neoplasms; Solid tumours	Details
Enozertinib	ORIC-114; VRN-07	Phase 2 Clinical	Voronoi Inc	Carcinoma, Non-Small-Cell Lung; Solid tumours	Details
Nesfrotamig	ABL105; YH-32367	Phase 2 Clinical	Abl Bio Inc	Breast Neoplasms; Solid tumours; Stomach Neoplasms	Details
EB-DT-CAR-NK	EB-DT-CAR-NK	Phase 2 Clinical	Beijing Biotech	Breast Neoplasms; Triple Negative Breast Neoplasms	Details
EB-DuoNK-MSLN/HER2 cell therapy (Beijing Biotech)		Phase 2 Clinical	Beijing Biotech	Carcinoma, Non-Small-Cell Lung	Details
HER2 FPBMC therapy (University Of Virginia)	HER2 FPBMC	Phase 2 Clinical	University Of Virginia	Breast Neoplasms; Prostatic Neoplasms	Details
CLIO-8221	HMBD-802; HMBD802; CLIO8221; CLIO-8221	Phase 2 Clinical	Hummingbird Bioscience	Solid tumours	Details
99mTc-ZHER2:41071		Phase 2 Clinical	Tomsk National Research Medical Center Of The Russian Academy Of Sciences	Breast Neoplasms	Details
68-GaNOTA-Anti-HER2 VHH1		Phase 2 Clinical	Universitair Ziekenhuis Brussel	Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Cholangiocarcinoma; Colorectal Neoplasms; Endometrial Neoplasms; Metastatic breast cancer; Pancreatic Neoplasms; Prostatic Neoplasms; Salivary Gland Neoplasms; Stomach Neoplasms; Uterine Neoplasms	Details
HMPL-A251	HMPLA251; HMPL-A251	Phase 2 Clinical		Solid tumours	Details
Pertuzumab biosimilar (Peking Union Medical College Hospital)		Phase 2 Clinical	Peking Union Medical College Hospital	Rectal Neoplasms	Details
Trastuzumab biosimilar (Peking Union Medical College Hospital)		Phase 2 Clinical	Peking Union Medical College Hospital	Rectal Neoplasms	Details
HER2 targeting chimeric antigen receptor T cell therapy (Essen Biotech)		Phase 2 Clinical	Essen Biotech	Osteosarcoma; Sarcoma; Sarcoma, Ewing; Sarcoma, Kaposi; Sarcoma, Synovial	Details
SYS-6045	SYS6045; SYS-6045	Phase 2 Clinical	Jushi Biopharmaceutical Co Ltd	Solid tumours	Details
YH-42946	YH42946; YH-42946	Phase 2 Clinical	Yuhan Corp	Carcinoma, Non-Small-Cell Lung; Solid tumours	Details
Neratinib (Fukang (Shanghai) Health Technology)	CVL009; CVL-009	Phase 2 Clinical	Convalife (Shanghai) Co Ltd	Carcinoma, Non-Small-Cell Lung; Solid tumours; Uterine Neoplasms	Details
JSKN-033	JSKN033; JSKN-033; JSKN-003/Envafolimab	Phase 2 Clinical	Jiangsu Alphamab Biopharmaceuticals Co Ltd	Carcinoma, Non-Small-Cell Lung; Neoplasms; Solid tumours; Uterine Cervical Neoplasms	Details
SHR-4602	SHR-4602; SHR4602	Phase 2 Clinical	Shanghai Suncadia Medicine Co Ltd, Suzhou Suncadia Biopharmaceuticals Co Ltd	Solid tumours	Details
HER2 Targeted HypoSti.CAR-T Cells(Chinese PLA General Hospital)		Phase 2 Clinical	Fudan University, Pla General Hospital	Solid tumours	Details
FDA022 Antibody Drug Conjugate	FDA022-BB05; F0034	Phase 2 Clinical	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd	Breast Neoplasms; Solid tumours	Details
I-025-A	I-025-A	Phase 2 Clinical	Shanghai Pharmaceuticals Holding Co Ltd	Breast Neoplasms; Colorectal Neoplasms	Details
BAT-8010	BAT-8010; BAT8010	Phase 2 Clinical	Bio-Thera Solutions Ltd	Solid tumours	Details
RAD-201	RAD-201	Phase 2 Clinical	Radiopharm Theranostics Ltd	Breast Neoplasms	Details
ST-1703	ST-1703	Phase 2 Clinical	Beijing Scitech-Mq Pharmaceuticals Ltd	Metastatic breast cancer; Solid tumours	Details
TL-938	TL-938	Phase 2 Clinical	Suzhou Teligene Ltd	Colorectal Neoplasms; Neoplasms	Details
SSGJ-705	SSGJ-705; 705	Phase 2 Clinical	Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd	Neoplasms; Solid tumours	Details
EO-1001	NT-113; APL-122	Phase 2 Clinical	Edison Pharmaceuticals Inc	Neoplasms	Details
SPH-5030	SPH-5030	Phase 2 Clinical	Shanghai Pharmaceuticals Holding Co Ltd	Bile Duct Neoplasms; Biliary Tract Neoplasms; Colorectal Neoplasms; Solid tumours	Details
IMM-2902	IMM-2902	Phase 2 Clinical		Breast Neoplasms; Cholangiocarcinoma; Lung Neoplasms; Solid tumours; Stomach Neoplasms	Details
Recombinant anti-HER2 humanized HuA21 monoclonal antibody(Hankemab)	HuA21; HuA-21	Phase 2 Clinical	Hefei Hankemab Biotechnology Co Ltd	Solid tumours; Stomach Neoplasms	Details
JRF-103	JRF103; JRF-103	Phase 2 Clinical	Shenzhen Jinrui Foundation Biotechnology Co Ltd	Solid tumours	Details
AIP-303	AIP-303	Phase 2 Clinical	Advanced Imaging Projects	Breast Neoplasms	Details
GQ-1001	GQ-1001	Phase 2 Clinical	GeneQuantum Healthcare (Suzhou) Co Ltd	Biliary Tract Neoplasms; Breast Neoplasms; Metastatic breast cancer; Solid tumours	Details
Epertinib	S-222611; RT1978; RT-1978	Phase 2 Clinical	Shionogi & Co Ltd	Neoplasms	Details
Pirotinib Hydrochloride	KBP-5209	Phase 2 Clinical	Shandong Xuanzhu Pharmaceutical Technology Co Ltd	Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Solid tumours	Details
Gancotamab	MM-302	Phase 2 Clinical	Merrimack Pharmaceuticals Inc	Breast Neoplasms; Ovarian Neoplasms	Details
Anti-CD3-anti-HER2-activated T cells		Phase 2 Clinical	Transtarget	Bone metastases; Breast Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant	Details
anti-HER2 ADC (Pfizer)	PF-06804103	Phase 2 Clinical	Pfizer Inc	Breast Neoplasms; Neoplasms; Triple Negative Breast Neoplasms	Details
ETBX-021	ETBX-021	Phase 2 Clinical	Etubics Corp, Nantbioscience Inc	Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Colorectal Neoplasms; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Squamous Cell Carcinoma of Head and Neck	Details
HER2(EQ)BBzeta/CD19 T cells (City of Hope)		Phase 1 Clinical	City Of Hope National Medical Center, Mustang Bio Inc	Glioma	Details
RG-6148	RG-6148; DHES-0815A	Phase 1 Clinical	F. Hoffmann-La Roche Ltd	Breast Neoplasms	Details
CIDeCAR		Phase 1 Clinical	Bellicum Pharmaceuticals Inc, National Cancer Institute	Osteosarcoma	Details
SC-CAR4BRAIN		Phase 1 Clinical	Seattle Children'S Hospital	Carcinoma; Carcinoma, Hepatocellular; Central Nervous System Neoplasms; Desmoplastic Small Round Cell Tumor; Diffuse Intrinsic Pontine Glioma; Diffuse midline glioma; Endodermal Sinus Tumor; Hepatoblastoma; Liposarcoma; Neoplasms, Germ Cell and Embryonal; Neuroblastoma; Neurofibrosarcoma; Osteosarcoma; Retinoblastoma; Rhabdoid Tumor; Rhabdomyosarcoma; Sarcoma; Sarcoma, Clear Cell; Sarcoma, Ewing; Sarcoma, Synovial; Solid tumours; Wilms Tumor	Details
99m-Tc labeled anti-HER2 single domain antibody (NanoMab)	99mTc-NM-02	Phase 1 Clinical	Nanomab Technology Ltd	Breast Neoplasms	Details
GB-235	GB-235	Phase 1 Clinical	Genor Biopharma Co Ltd	Breast Neoplasms	Details
HER-2/Neu pulsed DC1 vaccine (University of Pennsylvania)		Phase 1 Clinical	National Cancer Institute, University Of Pennsylvania	Breast Neoplasms	Details
Anti-HER2 monoclonal antibody-MCC-DM1 conjugate (Shanghai Pharma)	B-003 (Shanghai Pharma)	Phase 1 Clinical	Shanghai Crosslink Pharmaceutical R & D Co Ltd, Shanghai Pharmaceuticals Holding Co Ltd	Breast Neoplasms	Details
MP-0274	DARPin-41; SPA-28; CME-114; CME-115; CME-118; CME-119; MP-0274	Phase 1 Clinical	Molecular Partners Ag	Neoplasms	Details
TAS-0728	TPC-107; TAS-0728	Phase 1 Clinical	Taiho Pharmaceutical Co Ltd	Solid tumours	Details
68Ga-anti-HER2 nanobodies (Universite Libre de Bruxelles)		Phase 1 Clinical	Universite Libre De Bruxelles	Breast Neoplasms	Details
KY-1701	KY-1701	Phase 1 Clinical	Jiangsu Kanion Pharmaceutical Co Ltd	Breast Neoplasms	Details
Recombinant anti-HER2 subdomain II humanized monoclonal antibody(Livzon)	LZM-005	Phase 1 Clinical	Livzon Pharmaceutical Group Inc	Breast Neoplasms	Details
MX-402	MX-402	Phase 1 Clinical	Medvax Technologies	Stomach Neoplasms	Details
MB-103	MB-103 HER2 CAR; MB-103; HER2(EQ)BBζ/CD19t+ Tcm; HER2-BBζ CAR-T cells	Phase 1 Clinical	City Of Hope National Medical Center	Brain metastases; Breast Neoplasms; Glioblastoma; Meningeal Neoplasms; Neoplasms	Details
Fidasimtamab	IBI-315; BH-2950	Phase 1 Clinical	Hanmi Pharmaceutical Co Ltd	Neoplasms; Solid tumours	Details
Trastuzumab biosimilar (NeuClone/Serum Institute of India)		Phase 1 Clinical	Neuclone, Serum Institute Of India Ltd	Breast Neoplasms; Stomach Neoplasms	Details
Recombinant anti-HER2 humanized monoclonal antibody complex	B-002	Phase 1 Clinical	Shanghai Pharmaceuticals Holding Co Ltd	Breast Neoplasms; Metastatic breast cancer	Details
Runimotamab	RO-7227780; BTRC-4017A; RG-6194	Phase 1 Clinical	Genentech Inc	Solid tumours	Details
KSP-910638-G	KSP-910638G; KSP-910638-G	Phase 1 Clinical	University Of Michigan	Gastrointestinal Neoplasms	Details
TT-16	TT-16	Phase 1 Clinical	Tessa Therapeutics Ltd	Solid tumours	Details
Ado-trastuzumab emtansine biosimilar (Jiangsu Hengrui Medicine)	SHR-A1201	Phase 1 Clinical	Jiangsu Hengrui Medicine Co Ltd	Breast Neoplasms	Details
M-802(Wuhan Yzy Biopharma/CSPC Pharmaceutical)	M-802	Phase 1 Clinical	CSPC Pharmaceutical Group Ltd, Wuhan Yzy Biopharma Co Ltd	Breast Neoplasms; Ovarian Neoplasms; Solid tumours; Stomach Neoplasms	Details
Autologous-HER2-specific-T-cells	Autologous-HER2-specific-T-cells	Phase 1 Clinical	Baylor College Of Medicine	Brain Neoplasms; Sarcoma	Details
Recombinant anti-HER2 human monoclonal antibody-DM1 (Hisun Pharm/Mabworks Biotech)	HS-630; HS630	Phase 1 Clinical	Beijing Mabworks Biotech Co Ltd, Zhejiang Hisun Pharmaceutical Co Ltd	Breast Neoplasms	Details
Puvitinib		Phase 1 Clinical	Suzhou Teligene Ltd	Solid tumours	Details
Anti-HER2 CAR T-cell therapy (Seattle Children's Hospital)		Phase 1 Clinical	Seattle Children'S Research Institute	Central Nervous System Neoplasms	Details
[89Zr]-Df-Trastuzumab		Phase 1 Clinical	University Of Alabama At Birmingham	Breast Neoplasms; Neoplasms; Solid tumours	Details
KSP-QRH-E3-IRDye800		Phase 1 Clinical	University Of Michigan	Cholangiocarcinoma	Details
Pertuzumab biosimilar(SL Pharma/Combio)		Phase 1 Clinical	Beijing Kangming Bio New Drug Development Co Ltd, Beijing Sl Pharmaceutical Co Ltd	Breast Neoplasms; Inflammatory Breast Neoplasms; Metastatic breast cancer	Details
ZV-0203	ZV-0203; ZV203; ADC2122; ZV0203; ADC 2122	Phase 1 Clinical	Hangzhou Adcoris Biopharmacy Co Ltd	Solid tumours	Details
4-1BBz CD19-Her2tG (Seattle Children's Hospital)		Phase 1 Clinical	Seattle Children'S Hospital	Leukemia; Lymphoma; Neoplasms	Details
HER2.taNK	NK-92/5.28.z	Phase 1 Clinical	Nantkwest Inc	Glioblastoma	Details
PB-357	PB-357	Phase 1 Clinical	Pfizer Inc	Neoplasms	Details
Trastuzumab biosimilar (BioIntegrator)	BI-Mab-03	Phase 1 Clinical	Biointegrator Llc	Breast Neoplasms	Details
BAY-2701438	BAY-2701438	Phase 1 Clinical	Bayer AG	Neoplasms	Details
Neptinib Di-P-methylbenzenesulfonate		Phase 1 Clinical	Shenzhen Neptunus Pharmaceutical Research Institute Co Ltd	Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Stomach Neoplasms	Details
GB-251	GB-251; NBT-828; GB221-NBT828 ADC-1	Phase 1 Clinical	Genor Biopharma Co Ltd, Newbio Therapeutics Inc	Breast Neoplasms; Metastatic breast cancer	Details
HER.CAR-CMV-specific-CTLs	HER.CAR-CMV-specific-CTLs	Phase 1 Clinical	Baylor College Of Medicine	Glioblastoma	Details
ALT-P7	HM2-MMAE; ALT-P7	Phase 1 Clinical	Alteogen Inc	Breast Neoplasms; Stomach Neoplasms	Details
Trastuzumab imbotolimod	BDC-1001; Boltbody™ ISAC BDC-1001	Phase 1 Clinical	Bolt Biotherapeutics Inc	Breast Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Metastatic breast cancer; Neoplasms; Solid tumours	Details
anti-HER2 CAR macrophage therapy (The Affiliated Hospital of Xuzhou Medical University)		Phase 1 Clinical	The Affiliated Hospital Of Xuzhou Medical University	Ovarian Neoplasms	Details
anti-HER2 CAR T-cell therapy (Shanghai First Song Therapeutics)		Phase 1 Clinical	Shanghai Simcere Pharmaceutical Co Ltd	Colorectal Neoplasms; Metastatic breast cancer; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms	Details
EX-101 (Excelmab)		Phase 1 Clinical	ExcelMab Inc	Breast Neoplasms; Solid tumours; Stomach Neoplasms	Details
MHC class II HER-2/neu antigen vaccine (Marker Therapeutics)		Phase 1 Clinical	Mayo Clinic	Breast Neoplasms	Details
dual anti-HER2/anti-PD-L1 CAR T-cell therapy (Sichuan University)		Phase 1 Clinical	Sichuan University	Carcinoma, Non-Small-Cell Lung; Metastatic breast cancer; Ovarian Neoplasms; Peritoneal Neoplasms; Stomach Neoplasms	Details
SHR-1904	SHR-1904	Phase 1 Clinical	Jiangsu Hengrui Medicine Co Ltd	Pancreatic Neoplasms; Solid tumours	Details
[177Lu]Lu-ABY-271	177Lu-ABY-271	Phase 1 Clinical	Affibody Medical AB	Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Metastatic breast cancer; Ovarian Neoplasms; Stomach Neoplasms	Details
Autologous AdHER2 dendritic cell vaccine (National Cancer Institute)		Phase 1 Clinical	National Cancer Institute	Adenocarcinoma; Breast Neoplasms; Neoplasm Metastasis; Neoplasms	Details
VRN-10	VRN-101099; VRN-10	Phase 1 Clinical	Voronoi Inc	Neoplasms; Solid tumours	Details
NC-18	NC-18	Phase 1 Clinical	Novacyte Therapeutics Company Ltd	Solid tumours	Details
BC-004	BC-004	Phase 1 Clinical	Shandong Buchang Pharmaceuticals Co Ltd	Breast Neoplasms; Solid tumours	Details
Trastuzumab biosimilar (United BioPharma)	UB-921	Phase 1 Clinical	United Biopharma Inc	Breast Neoplasms	Details
TGFBeta-resistant-HER2-EBV-CTLs	TGFBeta-resistant-HER2-EBV-CTLs	Phase 1 Clinical	Baylor College Of Medicine	Neoplasms	Details
NeuCeptin	NeuCeptin	Phase 1 Clinical	Neuclone, Serum Institute Of India Ltd	Breast Neoplasms; Stomach Neoplasms	Details
SAR-446309	AMX-818; HER2-XPAT; SAR-446309; VIR-5818	Phase 1 Clinical	Amunix Pharmaceuticals Inc	Neoplasms; Solid tumours	Details
XMT-2056	XMT-2056	Phase 1 Clinical	Mersana Therapeutics Inc	Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Neoplasms; Stomach Neoplasms	Details
EB-DT-NK-UC101	EB-DT-NK-UC101	Phase 1 Clinical	Beijing Biotech	Carcinoma; Carcinoma, Transitional Cell; Urethral Neoplasms; Urinary Bladder Neoplasms	Details
CAN-016	CAN016; CAN-016	Phase 1 Clinical	Conway (Guangzhou) Biotechnology Co Ltd	Solid tumours	Details
Bmab-3000	Bmab3000; Bmab-3000	Phase 1 Clinical	Biocon Biologics UK Plc		Details
CGT-4255	CGT-4255; CGT4255	Phase 1 Clinical	Cogent Biosciences Inc	Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Solid tumours	Details
68Ga-SNA018	68Ga-SNA018; 68Ga-SNA-018; 68Ga-ADAPT6	Phase 1 Clinical	Kth Royal Institute Of Technology, Uppsala University	Breast Neoplasms; Stomach Neoplasms	Details
RR-M01	RR-M01; BM-1901	Phase 1 Clinical	Rock Roc Biotechnology Co Ltd	Solid tumours	Details
68Ga SGMIB-ZT-199	68Ga-SGMIB-ZT-199	Phase 1 Clinical	Huashan Hospital	Breast Neoplasms	Details
188Re-NM-02	188Re-NM-02	Phase 1 Clinical	NanoMab Technology (UK) Ltd, Shanghai Jiao Tong University Affiliated First People'S Hospital	Breast Neoplasms	Details
89Zr-LNCab072	89Zr-LNCab072	Phase 1 Clinical	Affiliated Hospital of Jiangnan University	Breast Neoplasms; Carcinoma, Transitional Cell; Stomach Neoplasms	Details
89Zr-LNCab002	89Zr-LNCab002	Phase 1 Clinical	Affiliated Hospital of Jiangnan University	Breast Neoplasms; Carcinoma, Transitional Cell; Stomach Neoplasms	Details
89Zr-LNCab190	89Zr-LNCab190	Phase 1 Clinical	Affiliated Hospital of Jiangnan University	Breast Neoplasms; Carcinoma, Transitional Cell; Stomach Neoplasms	Details
89Zr-LNCab104	89Zr-LNCab104	Phase 1 Clinical	Affiliated Hospital of Jiangnan University	Breast Neoplasms; Carcinoma, Transitional Cell; Stomach Neoplasms	Details
89Zr-LNCab103	89Zr-LNCab103	Phase 1 Clinical	Affiliated Hospital of Jiangnan University	Breast Neoplasms; Carcinoma, Transitional Cell; Stomach Neoplasms	Details
[111In]In-DOTA-TCO-trastuzumab		Phase 1 Clinical	Radboud University Medical Center	Solid tumours	Details
TGW-211	TGW-211; TRG001; TRG-001	Phase 1 Clinical	Tagworks Pharmaceuticals BV	Breast Neoplasms; Solid tumours; Stomach Neoplasms	Details
AK-2024	AK2024; AK-2024; BSI-128	Phase 1 Clinical	Biosion Inc	Solid tumours	Details
SYS-6040	SYS6040; SYS-6040	Phase 1 Clinical	Jushi Biopharmaceutical Co Ltd	Neoplasms; Neuroendocrine Tumors; Small Cell Lung Carcinoma; Solid tumours	Details
177 Lu-RAD202	177 Lu-RAD202	Phase 1 Clinical	Radiopharm Theranostics Ltd	Breast Neoplasms; Solid tumours; Stomach Neoplasms	Details
GenSci-139	GenSci-139; GenSci139	Phase 1 Clinical	Changchun GeneScience Pharmaceuticals Co Ltd	Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Colorectal Neoplasms; Solid tumours; Stomach Neoplasms	Details
Zanidatamab zovodotin	ZW-49	Phase 1 Clinical	Zymeworks Inc	Neoplasms	Details
SYS-6041	SYS6041; SYS-6041	Phase 1 Clinical	Jushi Biopharmaceutical Co Ltd	Neoplasms; Solid tumours	Details
Sirotinib Maleate	XZP-5491	Phase 1 Clinical	Shandong Xuanzhu Pharmaceutical Technology Co Ltd	Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Stomach Neoplasms	Details
BL-M17D1	BL-M17D1; BL-M217D1	Phase 1 Clinical	Baili-Bio (Chengdu) Pharmaceutical Co Ltd, Sichuan Baili Pharmaceutical Co Ltd	Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Fallopian Tube Neoplasms; Gastroesophageal Junction Neoplasms; Gastrointestinal Neoplasms; Metastatic breast cancer; Ovarian Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Solid tumours; Stomach Neoplasms	Details
NVL-330	NVL-330	Phase 1 Clinical	Nuvalent Inc	Neoplasms; Solid tumours	Details
IAM-1363	IAM-H1; ENT-H1; IAM1363; IAM-1363	Phase 1 Clinical	Iambic Therapeutics Inc	Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Central Nervous System Diseases; Colorectal Neoplasms; Neoplasm Metastasis; Neoplasms; Solid tumours; Stomach Neoplasms; Urinary Bladder Neoplasms	Details
Human HER2-targeted CAR-M cells therapy (Macera therapeutics)		Phase 1 Clinical	Nanjing Yuanmai Cell Biotechnology Co Ltd	Stomach Neoplasms	Details
AB-201(GC Cell)		Phase 1 Clinical	GC Cell Corp	Neoplasms	Details
MSH-2IA	MSH2IA; MSH-2IA	Phase 1 Clinical	Imagion Biosystems Ltd	Breast Neoplasms	Details
SIBP-A17	SIBP-A17; SIBPA17	Phase 1 Clinical	Shanghai Institute of Biological Products Co Ltd	Solid tumours	Details
Anti-HER2-CAR-T Cells Therapy(First Song Therapeutics)		Phase 1 Clinical	China Medical University, China, Shanghai First Song Therapeutics Co Ltd	Solid tumours	Details
[68Ga]ABY-025	ABY-025; 68GaABY025; [68Ga]-ABY-025; ABY-025-[68Ga]; Gallium-68-ABY-025; [68Ga]Ga-ABY-025 PET	Phase 1 Clinical	Affibody Ab	Breast Neoplasms; Esophageal Squamous Cell Carcinoma; Neoplasm Metastasis; Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms	Details
89Zr-DFO*Trastuzumab		Phase 1 Clinical	Astrazeneca Plc	Breast Neoplasms; Metastatic breast cancer; Stomach Neoplasms	Details
[123I] I-(HE)3-G3		Phase 1 Clinical	Tomsk National Research Medical Center Of The Russian Academy Of Sciences	Breast Neoplasms	Details
D3L-001	D3L-001	Phase 1 Clinical	D3 Bio (Wuxi) Co Ltd	Neoplasms; Solid tumours	Details
KY-1702	KY-1702; KY1702	Phase 1 Clinical	Jiangsu Kanion Pharmaceutical Co Ltd	Carcinoma, Non-Small-Cell Lung	Details
SNC-109	SNC109; SNC-109	Phase 1 Clinical	Shanghai Simnova Biotechnology Co Ltd	Glioblastoma	Details
XZP-KM501	XZP-KM501; KM-501	Phase 1 Clinical	Xuanzhu (Shijiazhuang) Biotechnology Co Ltd	Neoplasm Metastasis; Solid tumours	Details
SMP-656	SMP-656	Phase 1 Clinical	Chengdu Xilinglab Pharmaceutical Co Ltd	Neoplasms; Solid tumours	Details
ELVN-002	ELVN-002	Phase 1 Clinical	Enliven Therapeutics Inc	Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Metastatic breast cancer; Solid tumours; Stomach Neoplasms	Details
CPO-204	CPO-204	Phase 1 Clinical	CSPC Pharmaceutical Group Ltd	Carcinoma, Transitional Cell	Details
99mTc-MIRC213	99-mTc-MIRC-213	Phase 1 Clinical	Peking Union Medical College Hospital	Breast Neoplasms	Details
TY4028	TY-4028; TY4028	Phase 1 Clinical	TYK Medicines Inc	Carcinoma, Non-Small-Cell Lung; Neoplasms	Details
FT-825	ONO-8250; FT-825; ONO 8250/FT 825	Phase 1 Clinical	Memorial Sloan Kettering Cancer Center	Solid tumours	Details
Recombinant human ErbB3 fragment vaccine (Zensun)	rhErbB3-f	Phase 1 Clinical	Zensun (Shanghai) Sci&Tech Co Ltd	Neoplasms	Details
Allogeneic blood-derived NK cell therapy (NKGen Biotech)	SNK-02; SNK02; CAR-SNK-02	Phase 1 Clinical	NKGen Biotech Inc	Neoplasm Metastasis; Neoplasms; Solid tumours	Details
KMHH-03	KMHH-03; KMHH03	Phase 1 Clinical	Beijing Kangming Haihui Biological Technology Co Ltd	Breast Neoplasms	Details
Pertuzumab biosimilar (biocad)	BCD-178	Phase 1 Clinical	BIOCAD JSC	Breast Neoplasms	Details
99mTc- ADAPT6	99mTc- ADAPT6; ADAPT6; SNA-018; 99mTc-SNA-018	Phase 1 Clinical	Kth Royal Institute Of Technology, Uppsala University	Breast Neoplasms	Details
99mTc-HE3-G3	99mTc-HE3-G3; 99-mTc-HE-3-G-3; 99m-Tc-HE-3-G-3; 99mTc-(HE)3-G3; 99mTc-(CO)3-(HE)3-Ec1; [99mTc]Tc(CO)3-(HE)3-Ec1	Phase 1 Clinical	Tomsk National Research Medical Center Of The Russian Academy Of Sciences	Breast Neoplasms; Solid tumours	Details
227Th-Trastuzumab corixeta	BAY-2701439	Phase 1 Clinical	Bayer AG	Neoplasms	Details
XZP-KM257	XZP-KM257; KM-257	Phase 1 Clinical	Beijing Kangming Bio New Drug Development Co Ltd	Solid tumours	Details
PM-3002	PM-3002	Phase 1 Clinical			Details
XZP-5209	XZP-5209	Phase 1 Clinical	Xuanzhu (Shijiazhuang) Biotechnology Co Ltd	Carcinoma, Non-Small-Cell Lung	Details
SAR-443216	SAR-443216	Phase 1 Clinical	Sanofi	Breast Neoplasms; Lung Neoplasms; Neoplasms; Solid tumours; Stomach Neoplasms	Details
NIP-142	NIP-142	Phase 1 Clinical	National Institutes Of Pharmaceutical Research And Development Co Ltd	Carcinoma, Non-Small-Cell Lung	Details
Anti-HER2 CAR T-cell therapy (Baylor College of Medicine/The Hospital for Sick Children/Texas Children's Hospital/The Methodist Hospital System )		Phase 1 Clinical	Baylor College Of Medicine, Texas Children'S Hospital, The Hospital For Sick Children, The Methodist Hosp Research Institute	Sarcoma	Details
HER-2 Specific CAR T Cell		Phase 1 Clinical	Pediatric Brain Tumor Consortium (Pbtc), St. Jude Children'S Research Hospital	Ependymoma	Details
AB-201 (Artiva Biotherapeutics)	GCC2003; AB-201 (Artiva Biotherapeutics); GCC-2003	Phase 1 Clinical	GC Cell Corp	Breast Neoplasms; Gastroesophageal Junction Neoplasms; Neoplasms; Solid tumours; Stomach Neoplasms	Details
89Zr-ss-Pertuzumab		Phase 1 Clinical	Genentech Inc	Breast Neoplasms; Metastatic breast cancer	Details
SSGJ-612	SSGJ-612	Phase 1 Clinical	Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd	Neoplasms; Solid tumours	Details
Pertuzumab biosimilar(EirGenix)	EG-1206A; EG-1206-A	Phase 1 Clinical	Eirgenix Inc	Breast Neoplasms	Details
Dual-targeting HER2 and PD-L1 CAR-T Cell Therapy (Sichuan University)		Phase 1 Clinical	Sichuan University	Peritoneal Neoplasms; Pleural Effusion, Malignant	Details
CT-0508	CT-0508	Phase 1 Clinical	Carisma Therapeutics Inc	Solid tumours	Details
CCT303-406	CCT3-HER2-0406; CCT303-406	Phase 1 Clinical	BioAtla Inc	Breast Neoplasms; Ovarian Neoplasms; Sarcoma; Solid tumours; Stomach Neoplasms	Details
EX-101	EX-101; EX101	Phase 1 Clinical	Guangzhou Excelmab Inc	Solid tumours	Details
DZD-1516	DZD-1516	Phase 1 Clinical	Dizal (Jiangsu) Pharmaceutical Co Ltd	Breast Neoplasms; Metastatic breast cancer	Details
MBS-301	MBS-301	Phase 1 Clinical	Beijing Mabworks Biotech Co Ltd	Breast Neoplasms; Solid tumours; Stomach Neoplasms	Details
FCN-411	FCN-411	Phase 1 Clinical		Carcinoma, Non-Small-Cell Lung; Lung Neoplasms	Details
ACE-1702	ACE-1702	Phase 1 Clinical	Acepodia Taiwan Subsidiary	Metastatic breast cancer; Neoplasm Metastasis; Solid tumours; Stomach Neoplasms	Details
CX510	CX510; CX-510	Phase 1 Clinical	Hangzhou Aojin Biomedical Technology Co Ltd, Hangzhou Sanyintai Pharmaceutical Technology Co Ltd	Carcinoma, Non-Small-Cell Lung; Solid tumours	Details
Recombinant anti-HER2 humanized monoclonal antibody (Shenzhen Main Luck Pharmaceuticals)		Phase 1 Clinical	Shenzhen Main Luck Pharmaceuticals Inc	Breast Neoplasms	Details
Recombinant anti-HER2 domain II humanized monoclonal antibody (Qilu Pharmaceutical)		Phase 1 Clinical	Qilu Pharmaceutical Co Ltd	Breast Neoplasms	Details
Trastuzumab biosimilar (BioXpress)	BXT-2318; BX-2318	Clinical	Bioxpress Therapeutics Sa	Metastatic breast cancer; Stomach Neoplasms	Details
IBPM003TZ (Inbiopro Solutions)	IBPM-003TZ	Clinical	Inbiopro Solutions	Breast Neoplasms	Details
99-mTc-ABH-2		Clinical	Peking Union Medical College Hospital	Breast Neoplasms	Details
IBPM002BZ (Inbiopro Solutions)	IBPM-002BZ	Clinical	Inbiopro Solutions	Carcinoma, Renal Cell; Colorectal Neoplasms; Small Cell Lung Carcinoma	Details
131I SGMIB-ZT-199	131I-SGMIB-ZT-199	Clinical	Huashan Hospital	Breast Neoplasms	Details
18F-HER2 PET		Clinical	First Affiliated Hospital Of Zhejiang University	Carcinoma, Transitional Cell	Details
[18F]F-RESCA-RB14		Clinical	Renji Hospital Affiliated To Shanghai Jiaotong University School Of Medicine	Digestive System Neoplasms	Details
[68Ga]Ga-DOTA-H2D3		Clinical	Renji Hospital Affiliated To Shanghai Jiaotong University School Of Medicine	Digestive System Neoplasms	Details
68Ga-Her2-affibody	68Ga-Her2-affibody	Clinical	The First Affiliated Hospital Of Beijing University	Neoplasms	Details
Anti-HER2 CAR-T cell therapy (UTC Therapeutics)		Clinical	UTC Therapeutics Inc	Solid tumours	Details
99mTc-DARPinG3	99mTc-DARPinG3; 99mTc-DARPinG-3	Clinical	Tomsk National Research Medical Center Of The Russian Academy Of Sciences	Breast Neoplasms	Details
99mTc-MIRC208		Clinical	Beijing Cancer Hospital	Neoplasms	Details
[18F]GE-226	GE-226-[18F]; Fluorine-18-GE-226; [18F]GE-226; 18F-GE-226	Clinical	Affibody Ab	Breast Neoplasms	Details
GW-2974	GW-2974		Glaxosmithkline Plc	Neoplasms	Details
[99mTc]Tc-G3-(G3S)3C			Tomsk National Research Medical Center Of The Russian Academy Of Sciences	Breast Neoplasms	Details

Marketed Drug Information

English Name	Research Code	Highest Development Stage	Company	First Brand Name	First Approved Country	First Indication	First Approved Company	First Approved Date	Indication	Clinical Trial
Osimertinib Mesylate	AZD-9291; RDL94R2A16; AZD-9291 Mesylate; AZD9291	Approved	Astrazeneca Plc	泰瑞沙, Tagrisso	United States	Carcinoma, Non-Small-Cell Lung	Astrazeneca Pharmaceutical Co Ltd	2015-11-13	Adenocarcinoma; Adenocarcinoma of Lung; Brain metastases; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Colonic Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Glioblastoma; Glioma; Head and Neck Neoplasms; Hematologic Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma; Melanoma; Meningeal Neoplasms; Multiple Myeloma; Neoplasm, Residual; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Rectal Neoplasms; Skin Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Thyroid Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms	Details
Trastuzumab biosimilar (Celltrion)	CT-P6; CT-P06	Approved	Celltrion Inc	Herzuma	South Korea	Stomach Neoplasms; Breast Neoplasms	null	2014-01-01	Breast Neoplasms; Metastatic breast cancer; Stomach Neoplasms	Details
Trastuzumab emtansine biosimilar (Zydus Cadila)	ZRC-3256	Approved	Zydus Cadila	Ujvira	India	Breast Neoplasms	Zydus Cadila	2021-05-24	Breast Neoplasms	Details
Zanidatamab	JZP-598; ZW-25	Approved	Zymeworks Inc	Ziihera, 百赫安	United States	Biliary Tract Neoplasms	Jazz Pharmaceuticals Inc, Jazz Pharmaceuticals Plc	2024-11-20	Bile Duct Neoplasms; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Colonic Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal adenocarcinoma; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Metastatic breast cancer; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Rectal Neoplasms; Salivary Gland Neoplasms; Sarcoma; Stomach Neoplasms	Details
Trastuzumab biosimilar (Zhejiang Hisun Pharmaceutical)	HS-022	Approved	Zhejiang Hisun Pharmaceutical Co Ltd	安瑞泽	Mainland China	Stomach Neoplasms; Breast Neoplasms	Hisun Biopharmaceutical Co Ltd	2023-02-28	Breast Neoplasms; Stomach Neoplasms	Details
Trastuzumab biosimilar (Samsung Bioepis)	AMT-901; SB-3	Approved	Samsung Bioepis Co Ltd	Samfenet, Ontruzant	EU	Breast Neoplasms; Stomach Neoplasms	Samsung Bioepis Nl Bv	2017-11-15	Breast Neoplasms; Stomach Neoplasms	Details
Afatinib Dimaleate	BIBW-2992-MA2; BIBW-2992	Approved	C.H. Boehringer Sohn Ag & Co. Kg	Gilotrif, Giotrif, Tovok, 吉泰瑞, Tomtovok	United States	Carcinoma, Non-Small-Cell Lung	C.H. Boehringer Sohn Ag & Co. Kg	2013-07-12	Adenocarcinoma; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chordoma; Colorectal Neoplasms; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gallbladder Neoplasms; Gastroesophageal Junction Neoplasms; Glioblastoma; Glioma; Head and Neck Neoplasms; Hematologic Neoplasms; Liver Diseases; Lung Neoplasms; Lymphoma; Multiple Myeloma; Neoplasm Metastasis; Neoplasms; Neoplasms, Squamous Cell; Neuroectodermal Tumors; Penile Squamous Cell Carcinoma; Prostatic Neoplasms; Renal Insufficiency; Rhabdomyosarcoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Uterine Neoplasms	Details
Trastuzumab biosimilar (Synthon)	ABP-980	Approved	Synthon Bv	Kanjinti	EU	Breast Neoplasms; Stomach Neoplasms	Amgen Europe Bv	2018-05-16	Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Colonic Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal adenocarcinoma; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Glioma; Head and Neck Neoplasms; Hematologic Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma; Melanoma; Multiple Myeloma; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Rectal Neoplasms; Skin Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Thyroid Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms	Details
Mifanertinib Maleate	MET-306	Approved	Suzhou Maitai Bio-Technology Co Ltd	迈瑞东	Mainland China	Carcinoma, Non-Small-Cell Lung	Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd	2025-10-21	Carcinoma, Non-Small-Cell Lung; Solid tumours	Details
Trastuzumab biosimilar (Zydus)		Approved	Zydus Cadila	Vivitra	India	Breast Neoplasms	Zydus Cadila	2016-01-01	Breast Neoplasms	Details
Margetuximab	MGAH-22	Approved	Raven Biotechnologies Inc	Margenza	United States	Breast Neoplasms	Macrogenics Inc	2020-12-16	Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Metastatic breast cancer; Neoplasm Metastasis; Ovarian Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms	Details
Trastuzumab/Pertuzumab	RO-7198574; RG-6264	Approved	F. Hoffmann-La Roche Ltd	Phesgo, 赫捷康	United States	Breast Neoplasms	Genentech Inc	2020-06-29	Breast Neoplasms; Colorectal Neoplasms; Metastatic breast cancer	Details
Trastuzumab biosimilar (Reliance Life Sciences)	R-TPR-016	Approved	Reliance Life Sciences	TrastuRel	India	Breast Neoplasms	Reliance Life Sciences	2015-01-01	Breast Neoplasms	Details
Trastuzumab biosimilar (Anke Biotech)		Approved	Anhui Anke Biotechnology (Group) Co Ltd		Mainland China	Breast Neoplasms	Anhui Anke Biotechnology (Group) Co Ltd	2023-10-27	Breast Neoplasms	Details
Trastuzumab biosimilar (Hanwha Biologics)	HD-201	Approved	Hanwha Biologics	Tuznue, Hervelous	EU	Breast Neoplasms; Stomach Neoplasms	Prestige BioPharma Ltd	2024-09-19	Breast Neoplasms; Stomach Neoplasms	Details
Inetetamab	CMAB-302; 302(3SBio); 302H	Approved	Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd	Cipterbin, 赛普汀	Mainland China	Breast Neoplasms	Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd	2020-06-17	Breast Neoplasms; Metastatic breast cancer	Details
Trastuzumab biosimilar (Pfizer)	PF-5280014; PF-05280014	Approved	Pfizer Inc	Trazimera, trastuzumab-qyyp	EU	Breast Neoplasms; Stomach Neoplasms	Pfizer Europe Ma Eeig	2018-07-26	Breast Neoplasms; Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Colonic Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Glioma; Head and Neck Neoplasms; Hematologic Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma; Melanoma; Metastatic breast cancer; Multiple Myeloma; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Rectal Neoplasms; Skin Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Thyroid Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms	Details
Trastuzumab biosimilar (Alteogen)	ALT-L2; ALT-02; QL-1701; ALT-LS2	Approved	Alteogen Inc		Mainland China	Breast Neoplasms	Qilu Pharmaceutical Co Ltd	2024-06-28	Breast Neoplasms; Esophageal Neoplasms; Metastatic breast cancer; Stomach Neoplasms	Details
Trastuzumab biosimilar (CTTQ Pharma)	TQ-B211	Approved	Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd	赛妥	Mainland China	Breast Neoplasms; Stomach Neoplasms	Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group	2023-07-25	Breast Neoplasms; Metastatic breast cancer; Stomach Neoplasms	Details
Trastuzumab biosimilar (AXXO)		Approved	Axxo						Breast Neoplasms	Details
Trastuzumab rezetecan	SHR-A1811	Approved	Jiangsu Hengrui Medicine Co Ltd	艾维达	Mainland China	Carcinoma, Non-Small-Cell Lung	Suzhou Suncadia Biopharmaceuticals Co Ltd	2025-05-27	Bile Duct Neoplasms; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Genital Neoplasms, Female; HR-positive breast cancer; Lymphangioma, Cystic; Metastatic breast cancer; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Salivary Gland Neoplasms; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms; Uterine Cervical Neoplasms	Details
Trastuzumab biosimilar (Biocon/Mylan)	Bmab-200; Myl-1401O; HerMyl-1401O	Approved	Biocon Ltd, Mylan Nv	CANMAb, Ogivri, Zedora, Hertraz	India	Breast Neoplasms; Esophageal Neoplasms; Stomach Neoplasms	null	2013-01-01	Breast Neoplasms; Carcinoma, Ductal, Breast; Esophageal adenocarcinoma; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Stomach Neoplasms; Uterine Cervical Neoplasms	Details
Trastuzumab botidotin	A-166	Approved	Sichuan Kelun Pharmaceutical Co Ltd	舒泰莱	Mainland China	Breast Neoplasms	Sichuan Kelun-Biotech Biopharmaceutical Co Ltd	2025-10-14	Bile Duct Neoplasms; Breast Neoplasms; Carcinoma, Mucoepidermoid; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Cholangiocarcinoma; Colonic Neoplasms; Colorectal Neoplasms; Cystadenocarcinoma, Mucinous; Gastroesophageal Junction Neoplasms; Head and Neck Neoplasms; Laryngeal Neoplasms; Lip Neoplasms; Liver Neoplasms; Lung Neoplasms; Metastatic breast cancer; Mouth Neoplasms; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms; Rare Diseases; Rectal Neoplasms; Salivary Gland Neoplasms; Skin Neoplasms; Solid tumours; Stomach Neoplasms; Tongue Neoplasms; Tonsillar Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Uterine Cervical Neoplasms	Details
Trastuzumab	R-597; RO45-2317; Anti-HER2/neu-MAb; huMAb4D5-8; RG-597; MKC-454	Approved	Genentech Inc	Herceptin, 赫赛汀	United States	Breast Neoplasms	Genentech Inc	1998-09-25	Adenocarcinoma; Breast Diseases; Breast Neoplasms; Carcinoma, Acinar Cell; Carcinoma, Mucoepidermoid; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Colonic Neoplasms; Endometrial Neoplasms; Ependymoma; Gastroesophageal Junction Neoplasms; Head and Neck Neoplasms; Lung Neoplasms; Meningeal Carcinomatosis; Metastatic breast cancer; Neoplasm Metastasis; Neoplasms; Neoplastic Cells, Circulating; Prostatic Neoplasms; Salivary Gland Neoplasms; Sarcoma; Solid tumours; Stomach Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vulvar Diseases	Details
Trastuzumab biosimilar (Intas Pharmaceuticals)		Approved	Intas Biopharmaceuticals						Breast Neoplasms	Details
Tucatinib	ARRY-380; ONT-380; MK-7119	Approved	Array Biopharma	Tukysa	United States	Breast Neoplasms	Seagen Inc	2020-04-17	Breast Neoplasms; Colorectal Neoplasms; Gastroesophageal Junction Neoplasms; Hepatic Insufficiency; Meningeal Neoplasms; Metastatic breast cancer; Neoplasm Metastasis; Neoplasms; Stomach Neoplasms	Details
Ado-trastuzumab emtansine	RG-3502; R-3502; T-DM1; PRO-132365; RO-5304020	Approved	Genentech Inc	Kadcyla, 赫赛莱	United States	Breast Neoplasms	Genentech Inc	2013-02-22	Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Hematologic Neoplasms; Lung Neoplasms; Lymphoma; Metastatic breast cancer; Multiple Myeloma; Neoplasm Metastasis; Pancreatic Neoplasms; Salivary Gland Neoplasms; Solid tumours; Stomach Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms	Details
Trastuzumab biosimilar (Dr. Reddy's Laboratories)		Approved	Dr.Reddy's Laboratories Ltd	Hervycta	India	Breast Neoplasms	Dr.Reddy's Laboratories Ltd	2018-07-26	Breast Neoplasms	Details
Zenocutuzumab	MCLA-128	Approved	Merus Nv	Bizengri	United States	Pancreatic Neoplasms; Carcinoma, Non-Small-Cell Lung	Merus Nv	2024-12-04	Carcinoma, Non-Small-Cell Lung; Metastatic breast cancer; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Solid tumours	Details
Pertuzumab	rhuMab-2C4; RO-4368451; R-1273; RG-1273; RO-4368451-F01; rhuMAb2C4; Ro 436-8451/F01; RO4368451	Approved	F. Hoffmann-La Roche Ltd, Genentech Inc	帕捷特, Perjeta, Omnitarg	United States	Breast Neoplasms	Genentech Inc	2012-06-08	Adrenal Gland Neoplasms; Breast Neoplasms; Carcinoid Tumor; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Fallopian Tube Neoplasms; Gastroesophageal Junction Neoplasms; Metastatic breast cancer; Multiple Endocrine Neoplasia; Neoplasm Metastasis; Neoplasms; Neuroblastoma; Neuroendocrine Tumors; Ovarian Neoplasms; Pancreatic Neoplasms; Pancreatic neuroendocrine tumors (pNET); Peritoneal Neoplasms; Prostatic Neoplasms; Rectal Neoplasms; Solid tumours; Stomach Neoplasms	Details
Trastuzumab/Hyaluronidase		Approved	Genentech Inc	Herceptin Hylecta	United States	Breast Neoplasms	Genentech Inc	2019-02-28	Breast Neoplasms	Details
Fam-trastuzumab deruxtecan	DS-8201a; DS-8201; VRN-101099; T-DXd	Approved	Daiichi Sankyo Co Ltd	Enhertu, 优赫得, 優赫得	United States	Breast Neoplasms	Daiichi Sankyo Co Ltd	2019-12-20	Adenocarcinoma; Bile Duct Neoplasms; Brain metastases; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Gastrointestinal Neoplasms; Glioblastoma; Meningeal Neoplasms; Metastatic breast cancer; Neoplasm Metastasis; Neoplasms; Neoplasms, Glandular and Epithelial; Osteosarcoma; Ovarian Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms	Details
Trastuzumab biosimilar (Shanghai Henlius Biotech)	HLX-02	Approved		Zercepac, 汉曲优, HERCESSI	EU	Breast Neoplasms; Stomach Neoplasms	Accord Healthcare Slu	2020-07-27	Breast Neoplasms; Neoplasms; Stomach Neoplasms	Details
Trastuzumab biosimilar (Biocad)	BCD-022	Approved	BIOCAD JSC	HERtiCAD	Russian Federation	Breast Neoplasms	BIOCAD JSC	2016-01-01	Breast Neoplasms	Details
Pertuzumab biosimilar (Shanghai Henlius Biotech)	HLX-11	Approved		POHERDY	United States	Breast Neoplasms	Shanghai Henlius Biologics Co Ltd, Shanghai Henlius Biotech Inc	2025-11-13	Breast Neoplasms; Metastatic breast cancer	Details
Pertuzumab biosimilar (Hisun Biopharma)		Approved	Hisun Biopharmaceutical Co Ltd	贝泽汀	Mainland China	Breast Neoplasms	Hisun Biopharmaceutical Co Ltd	2026-02-02	Breast Neoplasms	Details
Trastuzumab biosimilar(Curateq Biologics)	BP02; BP-02	Approved	CuraTeQ Biologics Pvt Ltd		EU	Stomach Neoplasms; Breast Neoplasms	CuraTeQ Biologics SRO	2025-06-30	Breast Neoplasms; Neoplasms; Stomach Neoplasms	Details
Neratinib Maleate	HKI-272; PF-0528767; WAY-179272; CAN-030; PB-272	Approved	Pfizer Inc	Nerlynx, 贺俪安, 汉奈佳, 赫赛佳, Hernera	United States	Breast Neoplasms	Puma Biotechnology Inc	2017-07-17	Brain metastases; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Glioblastoma; Hepatic Insufficiency; Lung Neoplasms; Metastatic breast cancer; Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms	Details
Lapatinib Ditosylate Hydrate	GW-572016; GW-572016F; GW-2016	Approved	Glaxosmithkline Plc, Novartis Pharma Ag	Tykerb, Tyverb, 泰立沙, Tykerb/Tyverb	United States	Breast Neoplasms	Novartis Pharma Ag	2007-03-13	Abdominal Neoplasms; Adenocarcinoma; Astrocytoma; Bile Duct Neoplasms; Brain metastases; Brain Neoplasms; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma; Carcinoma, Acinar Cell; Carcinoma, Adenoid Cystic; Carcinoma, Hepatocellular; Carcinoma, Mucoepidermoid; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Carcinoma, Verrucous; Central Nervous System Neoplasms; CNS Embryonal Tumor; Colorectal Neoplasms; Endometrial Neoplasms; Ependymoma; Esophageal Neoplasms; Gallbladder Neoplasms; Gastroesophageal Junction Neoplasms; Gastrointestinal Neoplasms; Glioblastoma; Glioma; Gliosarcoma; Head and Neck Neoplasms; Hypopharyngeal Neoplasms; Laryngeal Diseases; Laryngeal Neoplasms; Lip Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma; Medulloblastoma; Melanoma; Metastatic breast cancer; Mouth Neoplasms; Nasopharyngeal Carcinoma; Neoplasm Metastasis; Neoplasms; Neoplasms, Gonadal Tissue; Neurofibromatosis 2; Neuroma, Acoustic; Nose Neoplasms; Oligoden	Details
Trastuzumab biosimilar (EirGenix/Sandoz)	EG-12014; EGI 014A1; EGI-014	Approved	Eirgenix Inc, Sandoz		EU	Breast Neoplasms; Stomach Neoplasms	Sandoz Gmbh	2023-11-15	Breast Neoplasms; Stomach Neoplasms	Details
Sevabertinib	BAY-2927088	Approved	Bayer AG, Broad Institute, Harvard University	Hyrnuo	United States	Carcinoma, Non-Small-Cell Lung	Bayer Healthcare Pharmaceuticals Inc, Bayer Healthcare Pharmaceuticals Llc	2025-11-19	Carcinoma, Non-Small-Cell Lung; Hepatic Insufficiency; Liver Diseases; Neoplasm Metastasis; Solid tumours	Details
Zongertinib	BI-1810631	Approved	Boehringer Ingelheim International Gmbh	HERNEXEOS, 圣赫途	United States	Carcinoma, Non-Small-Cell Lung	Boehringer Ingelheim Pharmaceuticals Inc	2025-08-08	Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Esophageal adenocarcinoma; Gastroesophageal Junction Neoplasms; Liver Diseases; Lung Neoplasms; Metastatic breast cancer; Neoplasm Metastasis; Solid tumours; Stomach Neoplasms	Details
Pertuzumab biosimilar (Qilu Pharmaceutical)	QL-1209; QL1209	Approved	Qilu Pharmaceutical Co Ltd	安赛珠	Mainland China	Breast Neoplasms	Qilu Pharmaceutical Co Ltd	2024-12-17	Breast Neoplasms	Details
Trastuzumab biosimilar (AryoGen Pharmed)		Approved	Aryogen Biopharma	AryoTrust					Breast Neoplasms; Stomach Neoplasms	Details
Pertuzumab biosimilar (CTTQ)	TQB-2440	Approved	Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd	帕乐坦	Mainland China	Breast Neoplasms	Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group	2024-12-17	Breast Neoplasms	Details
Disitamab Vedotin	RC-48-ADC; RC48-ADC; RC-48	Approved		爱地希, Aidixi	Mainland China	Stomach Neoplasms	RemeGen Co Ltd	2021-06-08	Bile Duct Neoplasms; Biliary Tract Neoplasms; Breast Diseases; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Endometrial Neoplasms; Gastroesophageal Junction Neoplasms; Genital Diseases, Female; Genital Neoplasms, Female; Head and Neck Neoplasms; Liver Neoplasms; Melanoma; Metastatic breast cancer; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Paget Disease, Extramammary; Prostatic Neoplasms, Castration-Resistant; Solid tumours; Stomach Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms	Details
Pyrotinib Maleate	BLTN; HTI-1001; SHR-1258	Approved	Jiangsu Hengrui Medicine Co Ltd	艾瑞妮	Mainland China	Breast Neoplasms	Jiangsu Hengrui Medicine Co Ltd	2018-08-12	Adenocarcinoma of Lung; Bile Duct Neoplasms; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Gastroesophageal Junction Neoplasms; Gastrointestinal Neoplasms; Lung Neoplasms; Metastatic breast cancer; Neoplasms; Solid tumours; Stomach Neoplasms	Details
Dacomitinib	PF-00299804-03; PF-00299804-3; PF-00299804; PF-299804; PF-299; PF-804	Approved	Pfizer Inc	Vizimpro	United States	Carcinoma, Non-Small-Cell Lung	Pfizer Inc	2018-09-27	Adenocarcinoma; Brain Neoplasms; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Colorectal Neoplasms; Esophageal Squamous Cell Carcinoma; Glioblastoma; Head and Neck Neoplasms; Liver Diseases; Lung Neoplasms; Mouth Neoplasms; Neoplasm Metastasis; Neoplasms; Penile Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms	Details

Customer Reviews

M***e2025-03-13
Biotinylated Human Her2 / ErbB2 Protein, His,Avitag™, premium grade
Great pricing and great products! Improvement would be to give open access to the technical information (e.g. protocols and reconstitution details).
G***z2025-03-12
Human Her2 / ErbB2 Protein, His Tag (Mass Spec & MALS verified)
We bought the Her2 to perform SPR to determine the binding affinity of in house produced herceptin. Using the His tag it was easy to capture the protein with amine coupled anti His antibody on the sensor chip surface. Therefore we could prove our antibody has full binding functionality very easily using the biacore T200 system. Ordering and shipping was really simple and all the necessary documentation can be found online. Although I didn't find the CoA in the first place everything was described easily and protocols of different analyses were available.
M***t2025-01-15
Biotinylated Human Her2 / ErbB2 Protein, His,Avitag™, premium grade
I used the biotinylated HER2 antigen from ACRO Biosystems for several applications, including phage panning, BLI, and phage ELISA, and it performed very well across all assays. The high purity and specific biotinylation allowed for reliable streptavidin binding, ensuring reproducible results. I have had very good luck with all Acro products during my career in science. Highly recommended for precision-driven workflows!
C***n2025-01-13
Mouse Her2 / ErbB2 Protein, His Tag (MALS verified)
I bought this pufiried protein to assess crossreactivity. The logistics is fast and the experimental results reporducible. ACRO official website contais very comprehensible product info which has been really helpful for my PhD thesis project!
I***l2024-09-27
PE-Labeled Human Her2 / ErbB2 Protein, His Tag (Site-specific conjugation)
We used the PE-labeled recombinant ErbB2 protein to detect our HER2-specific CAR constructs. The protein performed exceptionally well, providing a strong and consistent fluorescence signal when analyzing stained samples via flow cytometry. The staining was highly specific, since we detected no background-signal on parental cell-lines lacking the CAR. This is in contrast to staining of CAR expressing cells using ErbB2-Fc in combination with secondary antibodies which often results in higher non-specific signals and is more time consuming. Hence, ErbB2-PE is a valuable tool to detect ErbB2-specific CAR expression via Flow cytometry.
m***t2023-01-09
Biotinylated Human Her2 / ErbB2 Protein, His Tag, ultra sensitivity (primary amine labeling, long spacer) (MALS verified)
I used this protein for four years now with no troubles. It's my reference for octet (BLI) analysis :). The biothynlation of the protein is a great advantage for this kind of use. Even after a long time at -80°C the protein is stable and works very well for our analysis. The disversity of chemical groups like polyHis moiety on this type of coumpound allow the use of the protein in various methods.
j***n2022-07-06
Biotinylated Human Her2 / ErbB2 Protein, His,Avitag™, premium grade
We use both the biotinylated and PE labeled version of this ERBB2 protein to detect our HER2-CAR in NK cells by flow cytometry. The biotinylated version works consistently well at a 1/200 dilution, and you can see a nice saturation curve if you titrate it. I do recommend making single use aliquots. The PE labeled also works well but you need to use a lot more of it.
1***22019-10-11
Human Her2 / ErbB2 Protein, Fc Tag, premium grade
The purchase of this product was mostly used for immunization and antibody screening, mainly for ELISA detection. This product was in stock at the time of purchase, so the delivery was very fast. The effects of immunization and detection are good, and the service is very good.
1***22019-10-12
Human Her2 / ErbB2 Protein, His Tag (Mass Spec & MALS verified)
The Her-2 protein has good bioactivity and can be detected by ELISA with a low coating concentration. The amount we used was small so it was cost-effective. I also bought another antigen which also showed really good bioactivity. Customer service is also excellent.

Trending Searches:

Her2

Her2

Her2 Overview

Her2 Product List

Can’t find what you need?

Project Cooperation

Clinical Drug Information

Marketed Drug Information